isradipine has been researched along with Hypertrophy, Right Ventricular in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakayama, K | 1 |
| Fukuta, Y | 1 |
| Kiyoshi, A | 1 |
| Iwatsuki, Y | 1 |
| Ishii, K | 1 |
| Ishikawa, T | 1 |
| Iida, M | 1 |
| Iwata, H | 1 |
| Enomoto, M | 1 |
1 other study available for isradipine and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
(+)-[3H]isradipine and [3H]glyburide bindings to heart and lung membranes from rats with monocrotaline-induced pulmonary hypertension.
Topics: Animals; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Calcium Channels, L-Type; Glyb | 1999 |